Global API Manufacturers of drugs for Candidiasis diseases,2016

1
Candidiasis-Global API Manufacturers, Marketed
and Phase III Drugs Landscape, 2016
Published on -  01 January, 2016 Number of pages
100 Single User Price 2000
Candidiasis Drug Market Development,2016 And
The Forecasting Details
2
Candidiasis is a yeast infection results from an
overgrowth of yeast (a type of fungus) anywhere
in the body. Candidiasis is by far the most
common type of yeast infection Key Objective A
key objective of the Candidiasis Report is to
understand the market and pipeline status of the
drugs around the Candidiasis to explore the
generic development opportunities, licensing
opportunities and to gain competitive advantage
on designing pipeline startegies. This provides
the historical and forecasted sales of the drugs
till 2018.  Covered in this report The Report
gives insights into patents providing the patent
protection data and marketing exclusivity of all
the drugs across the Candidiasis. While the
leading brands, companies and chemicals are
considered thoroughly, This report also provides
details on the Global API Manufacturers across
the globe covering Drug Master Filings of US,
Europe and API Manufacturers in Asia specifically
China and India. 
3
Candidiasis-Global API Manufacturers, Marketed
and Phase III Drugs Landscape, 2016 Report has
been prepared based on an in-depth market
analysis with inputs from industry experts. The
report covers the market landscape. The report
also includes the followings,

• Indication Overview 
• Market Drugs Landscape
• Global API Manufacturers Assessment
• Phase III Drugs Landscape 
• Drugs Market Data and Forecasted Sales
  Figure-2018
• Marketed Drugs for Candidiasis
• Phase III Drugs for Candidiasis
• Discontinued Drugs for Candidiasis
• Methodology

4

• SCOPE
• A snapshot of the global Market and Phase III
  therapeutics scenario for Candidiasis.
• A review of the marketed products under
  prescription for Candidiasis, regulatory
  information and marketing status.
• Coverage of global patent coverage and detailed
  commentaries on the US patent challenges. 
• Graphical representation of investigational
  products for patent expiry and market
  exclusivities across the globe.
• Product profiles for marketed products for
  Candidiasis with complete description of
  mechanism of action, therapeutic class, target,
  route(s) of administration and chemical details.
• Coverage of API Manufacturers for Candidiasis
  drugs in the United States, Europe and Asian
  Regions with location details.
• Coverage of Regulatory filings in theUS, Europe,
  and Asia specifically India and China for
  Candidiasis drugs.
• Coverage of Route of Synthesis of Active
  Pharmaceutical Ingredient associated with
  Candidiasis drugs.
• Coverage of Candidiasis Phase III pipeline
  products featuring sections on product
  description, mechanism of action, Chemical
  details and research development progress.
• Coverage of the United States Drug Master File
  (US DMF) available for Phase III Pipeline Drugs.
• Key discontinued Marketed products.
• Global Sales Figure to 2018.

Make an Inquiry Before Buying
Download Sample Brochure
5

• Key questions answered in this report 
• What is Candidiasis?
• What is the key Objective of the Candidiais
  Market Report?
• What are the historical And Forecasted Analysis
  about the Candidiasis Drug Market?
• How the Future market Of Candidiasis will be?
• What are the therapeutic assessment by different
  types taken for Candidiasis?
• You can request one free hour of our analysts
  time when you purchase this market report.
  Details are provided within the report.

Click Here To Check Complete Report
Inquiry about Discount
6
Candidiasis-Global API Manufacturers, Marketed
and Phase III Drugs Landscape, 2016

• A detailed qualitative analysis of the
  Candidiasis,commercial views is available in the
  report.

Contact 1-302-684-6088 sales_at_marketintelreports.c
om www.marketintelreports.com
Click here to order a copy of Candidiasis Report